CASP3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.229800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.743000E-01
Normal-vs-Stage2
8.956800E-01
Normal-vs-Stage3
4.105600E-01
Normal-vs-Stage4
5.684800E-01
Stage1-vs-Stage2
9.098600E-01
Stage1-vs-Stage3
5.827200E-01
Stage1-vs-Stage4
4.880400E-01
Stage2-vs-Stage3
3.448200E-01
Stage2-vs-Stage4
2.879800E-01
Stage3-vs-Stage4
2.574600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.101400E-01
Normal-vs-AfricanAmerican
9.452800E-01
Normal-vs-Asian
8.093000E-01
Caucasian-vs-AfricanAmerican
6.768800E-01
Caucasian-vs-Asian
9.886000E-01
AfricanAmerican-vs-Asian
7.064200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.807600E-01
Normal-vs-Female
8.950000E-01
Male-vs-Female
4.564000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.882200E-01
Normal-vs-Age(41-60Yrs)
8.800000E-01
Normal-vs-Age(61-80Yrs)
7.062600E-01
Normal-vs-Age(81-100Yrs)
5.857600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.042400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.946200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.074400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.426200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.197600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.962200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.537000E-01
Normal-vs-Daily Drinker
6.915800E-01
Normal-vs-Weekly Drinker
7.367400E-01
Normal-vs-Occasional Drinker
9.374400E-01
Normal-vs-Social Drinker
7.394400E-01
Non Drinker-vs-Daily Drinker
9.328200E-01
Non Drinker-vs-Weekly Drinker
8.428600E-01
Non Drinker-vs-Occasional Drinker
5.080800E-01
Non Drinker-vs-Social Drinker
1.715030E-01
Daily Drinker-vs-Weekly Drinker
9.071600E-01
Daily Drinker-vs-Occasional Drinker
5.876000E-01
Daily Drinker-vs-Social Drinker
2.191800E-01
Weekly Drinker-vs-Occasional Drinker
7.052400E-01
Weekly Drinker-vs-Social Drinker
2.899800E-01
Occasional Drinker-vs-Social Drinker
5.654000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.661200E-01
Normal-vs-Grade 2
1.216990E-01
Normal-vs-Grade 3
1.831430E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.240800E-03
Grade 1-vs-Grade 3
2.124500E-02
Grade 1-vs-Grade 4
4.661200E-01
Grade 2-vs-Grade 3
7.448600E-01
Grade 2-vs-Grade 4
1.216990E-01
Grade 3-vs-Grade 4
1.831430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.113800E-01
Normal-vs-NonDiabetic
8.199800E-01
Diabetic-vs-NonDiabetic
1.421370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.449400E-01
Normal-vs-NoPancreatitis
7.095400E-01
Pancreatitis-vs-NoPancreatitis
2.700200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.467200E-01
Normal-vs-N1
9.013800E-01
N0-vs-N1
4.576600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.479200E-01
Normal-vs-TP53-NonMutant
7.498800E-01
TP53-Mutant-vs-TP53-NonMutant
8.859800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
